Funding Opportunities
Pilot and Feasibility Program
We are no longer accepting applications for the 2024-2025 funding cycle.
Each year the Center's Pilot and Feasibility Program fosters and supports two year-long pilot projects in diabetes translational research led by promising early stage investigators. We expect to give out two 12-month awards awards each year, with a maximum of $40,000 awarded to each.
If you are interested in applying in the coming year, please see our most recent Request for Proposals (RFP) for eligibility information and detailed application instructions. An updated RFP for the next application cycle will be issued in January/February 2025.
Recently Completed Projects
AWARDEE NAME | AWARD DATES | PROJECT TITLE |
Sarah Haynes | 2022-2024 |
Testing a novel intervention to improve pediatric to adult transitions of care for adolescents and young adults with type 1 diabetes from low-income families |
Lauren Au | 2022-2024 |
Understanding the impact of GROWell: Goals for Reaching Optimal Wellness on improving offspring health and reducing risk of type 2 diabetes mellitus. |
Wagahta Semere | 2021-2024 |
Examining Clinical Decision-Making in Secure Messaging Communication among a Cohort of Racially/Ethnically Diverse Patients with Type 2 Diabetes and their Primary Care Physicians |
Rana Chehab | 2022-2023 |
Associations between Glycemic Control Trajectories among Individuals with Gestational Diabetes and Risk of Obesity and Growth Trajectories in the Offspring |
Luis Rodriguez | 2021-2022 |
Added Sugar Intake and Cardiometabolic Abnormality Among US Hispanic/Latino Adults |
Jennifer Falbe | 2021-2022 |
Impact of Sugar-sweetened Beverage (SSB) Warning Labels Among Low-income Hispanic Populations |
Alexandra Lee | 2020-2021 |
Investigating Alternative Glycemic Metrics to Predict Hypoglycemia and Hyperglycemia in Nursing Home Residents with Type 2 Diabetes |
Tainayah Thomas | 2020-2021 |
Engagement, Preferences and Perceptions Related to Diabetes Prevention Among Adults with Prediabetes |
Stephanie Hooker | 2020-2021 |
Improving Type 2 Diabetes Care Provided through Telehealth Modalities: Understanding Needs of Patients and Primary Care Providers |
2020-2021 |
Evaluating changes to primary care management and control of type 2 diabetes mellitus among diverse populations after wide-scale telehealth implementation | |
2019-2020 |
Perceptions and Preferences Related to Diabetes Prevention Among Individuals with Severe Mental Illness and Metabolic Risk Factors | |
2018-2019 |
Implementation and Effectiveness of Community Diabetes Prevention Programs in the United States | |
2018-2019 |
Investigation of Prevalence of and Barriers to Achieving Optimal Glycemic Control among Women with Gestational Diabetes | |
2017-2019 |
Pilot Study of eHealth Medication Messages for Latino Patients and Their Families | |
2017-2019 |
Tablet Research to Improve Understanding of Medications for People’s Health (TRIUMPH) | |
2016-2017 |
A Self-Affirmation Intervention to Enhance Patient Outreach for Health System-based Lifestyle Programs for Diabetes Prevention | |
2016-2017 |
Addressing Gaps in Research on Pay for Performance to Improve Quality of Diabetes Care: Provider Perspectives |
*=Core Faculty
Training Opportunities at Local Institutions
DREAMS-CDTR is not a training grant. However the center's core faculty is affiliated with a number of fellowship programs at its various member institutions. In addition to a T32 Training Program in Diabetes Translational Research, which aims to develop the next generation of researchers with the necessary skills to identify and overcome barriers to translating evidence into practice for patients with type 2 diabetes, DREAMS-CDTR members are affiliated with the UCSF CTSI KL2 Scholar Program.